Managed Healthcare Executive April 9, 2024
The Inflation Reduction Act proposes a significant initiative, the Drug Price Negotiation Program, aimed at tackling healthcare affordability and accessibility in the US. In this column, the importance of meaningful patient engagement during the IRA’s implementation is highlighted as a vital step towards improving health outcomes and equity for patients.
Designing the drug price negotiation program for and with patients
The IRA represents a potentially significant step towards making health care more affordable and accessible for all Americans. A key component of the IRA is the DPNP, which allows the federal government to negotiate prices for certain drugs with the highest total spending covered under Medicare. While the ultimate impact of the DPNP remains to be seen, it is clear...
Today's Sponsors
Today's Sponsor